140 related articles for article (PubMed ID: 38126101)
21. Leukemia cutis in B-cell chronic lymphocytic leukemia presenting as an episodic papulovesicular eruption.
Rosman IS; Nunley KS; Lu D
Dermatol Online J; 2011 Sep; 17(9):7. PubMed ID: 21971272
[TBL] [Abstract][Full Text] [Related]
22. Ibrutinib-Induced Skin Rash.
Kirar S; Gogia A; Gupta R; Mallick S
Turk J Haematol; 2021 Feb; 38(1):81-83. PubMed ID: 33053966
[No Abstract] [Full Text] [Related]
23. Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations.
Jain N; Thompson P; Burger J; Ferrajoli A; Takahashi K; Estrov Z; Borthakur G; Bose P; Kadia T; Pemmaraju N; Sasaki K; Konopleva M; Jabbour E; Garg N; Wang X; Kanagal-Shamanna R; Patel K; Wang W; Jorgensen J; Wang S; Lopez W; Ayala A; Plunkett W; Gandhi V; Kantarjian H; O'Brien S; Keating M; Wierda WG
Leukemia; 2021 Dec; 35(12):3421-3429. PubMed ID: 34007049
[TBL] [Abstract][Full Text] [Related]
24. Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine.
Nemets A; Ben Dor D; Barry T; Ducach A; Blumental R; Ben Alon D; Lugassy G
Leuk Lymphoma; 2003 Dec; 44(12):2151-4. PubMed ID: 14959863
[TBL] [Abstract][Full Text] [Related]
25. Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy.
Weiss MA; Glenn M; Maslak P; Rahman Z; Noy A; Zelenetz A; Scheinberg DA; Golde DW
Leukemia; 2000 Sep; 14(9):1577-82. PubMed ID: 10995003
[TBL] [Abstract][Full Text] [Related]
26. Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.
Robak T; Dmoszynska A; Solal-Céligny P; Warzocha K; Loscertales J; Catalano J; Afanasiev BV; Larratt L; Geisler CH; Montillo M; Zyuzgin I; Ganly PS; Dartigeas C; Rosta A; Maurer J; Mendila M; Saville MW; Valente N; Wenger MK; Moiseev SI
J Clin Oncol; 2010 Apr; 28(10):1756-65. PubMed ID: 20194844
[TBL] [Abstract][Full Text] [Related]
27. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
Hallek M
Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
[TBL] [Abstract][Full Text] [Related]
28. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia arising at the site of herpes zoster and herpes simplex scars.
Cerroni L; Zenahlik P; Kerl H
Cancer; 1995 Jul; 76(1):26-31. PubMed ID: 8630873
[TBL] [Abstract][Full Text] [Related]
29. Double remission of chronic lymphocytic leukemia and secondary acute myeloid leukemia after venetoclax monotherapy: A case report.
Wang L; Lin N
Medicine (Baltimore); 2021 Feb; 100(6):e24703. PubMed ID: 33578607
[TBL] [Abstract][Full Text] [Related]
30. Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study.
Kabadi SM; Near A; Wada K; Burudpakdee C
Adv Ther; 2020 Jul; 37(7):3129-3148. PubMed ID: 32399812
[TBL] [Abstract][Full Text] [Related]
31. Eosinophilic dermatosis of hematologic malignancy.
Farber MJ; La Forgia S; Sahu J; Lee JB
J Cutan Pathol; 2012 Jul; 39(7):690-5. PubMed ID: 22612903
[TBL] [Abstract][Full Text] [Related]
32. Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy.
Nakazawa H; Nishina S; Mimura Y; Kawakami T; Senoo Y; Sakai K; Nakazawa K; Kitano K
Int J Hematol; 2014 Jun; 99(6):782-5. PubMed ID: 24584911
[TBL] [Abstract][Full Text] [Related]
33. Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab.
Robak E; Biernat W; Krykowski E; Jeziorski A; Robak T
Leuk Lymphoma; 2005 Jun; 46(6):909-14. PubMed ID: 16019537
[TBL] [Abstract][Full Text] [Related]
34. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
35. Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.
Herishanu Y; Tadmor T; Braester A; Bairey O; Aviv A; Rahimi-Levene N; Fineman R; Levi I; Yuklea M; Ruchlemer R; Shvidel L; Polliack A
Hematol Oncol; 2019 Apr; 37(2):185-192. PubMed ID: 30756414
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous manifestations of B-cell chronic lymphocytic leukemia.
Morozova EA; Olisova OY; Nikitin EA
Int J Hematol; 2020 Oct; 112(4):459-465. PubMed ID: 32889697
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience.
Herishanu Y; Goldschmidt N; Bairey O; Ruchlemer R; Fineman R; Rahimi-Levene N; Shvidel L; Tadmor T; Ariel A; Braester A; Shapiro M; Joffe E; Polliack A;
Haematologica; 2015 May; 100(5):662-9. PubMed ID: 25661442
[TBL] [Abstract][Full Text] [Related]
38. [Eosinophilic dermatosis associated with hematological disorders: A clinical, histopathological and immunohistochemical study of six observations].
Chassine AF; Dadban A; Charfi S; Chaby G; Royer B; Damaj G; Chatelain D; Lok C
Ann Dermatol Venereol; 2010 Mar; 137(3):181-8. PubMed ID: 20227559
[TBL] [Abstract][Full Text] [Related]
39. Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.
Boddu P; Schlette E; Thakral B; Tang G; Pemmaraju N; Kadia T; Ferrajoli A; Ravandi F; Wierda W; Jain N
Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):161-165. PubMed ID: 28830803
[TBL] [Abstract][Full Text] [Related]
40. B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
Neuber K; Berg-Drewniock B; Volkenandt M; Neumaier M; Zeller W; Gross G; Ring J
Dermatology; 1996; 192(2):110-5. PubMed ID: 8829490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
